Trademark applications and grants for Hinova Pharmaceuticals Inc. Hinova Pharmaceuticals Inc has 2 trademark applications. The latest application filed is for "HINOVA"
Patent Application | Date |
---|---|
AROMATIC AMINE AR AHD BET TARGETING PROTEIN DEGRADATION CHIMERA COMPOUND AND USE 20220257774 - 17/595023 DU; Wu ;   et al. | 2022-08-18 |
AROMATIC AMINE COMPOUND AND USE THEREOF IN PREPARATION OF AR AND BRD4 DUAL INHIBITORS AND REGULATORS 20220177459 - 17/436347 DU; Wu ;   et al. | 2022-06-09 |
FAK inhibitor and drug combination thereof 20220125788 - 17/418678 DU; Wu ;   et al. | 2022-04-28 |
Histone acetylase p300 inhibitor and use thereof 20220087996 - 17/297965 FAN; Lei ;   et al. | 2022-03-24 |
DEUTERATED MGL-3196 COMPOUND AND USE THEREOF 20210292304 - 17/255231 DU; Wu ;   et al. | 2021-09-23 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
"HINOVA" 98364705 |
HINOVA 2024-01-18 |
"HINOVA" 87648525 |
HINOVA 2017-10-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.